A PHASE I STUDY OF UTOMILUMAB (PF-05082566), A 4-1BB/CD137...

Hematological Oncology 2017 / 06 Vol. 35

A PHASE I STUDY OF UTOMILUMAB (PF-05082566), A 4-1BB/CD137 AGONIST, IN COMBINATION WITH RITUXIMAB IN PATIENTS WITH CD20 + NON-HODGKIN'S LYMPHOMA

Gopal, A., Levy, R., Houot, R., Patel, S., Hatake, K., Popplewell, L., Chen, Y., Davis, C., Huang, B., Cesari, R., Thall, A., Woolfson, A., Bartlett, N.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
35
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.2438_127
Date:
June, 2017
File:
PDF, 71 KB
english, 2017
Conversion to is in progress
Conversion to is failed